Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Shattock: Novel Antigens for Mucosal Protection |
| Strategy: | Combo: DNA & protein vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Mouse |
| Stage: | Assays Completed |
| Study Start Date: | 2008-11-25 |
| Study Made Public: | 2010-12-28 |
Title
Neutralising activity of Murine monoclonal antibodies induced by C clade DNA prime and recombinant trimeric gp140 immunisation
Description
CAVD 321 is a preclinical mouse study of DNA and protein regimens.
Sign in to see full information about this study and to download study data.
Products
CN54gp140 DNA ZM96gp140 DNA CN54rgp140 proteinIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.